MOLECULAR CHARACTERIZATION OF MUSCARINIC RECEPTORS IN THE HUMAN VESTIBULAR PERIPHERY - IMPLICATIONS FOR PHARMACOTHERAPY

Citation
A. Ishiyama et al., MOLECULAR CHARACTERIZATION OF MUSCARINIC RECEPTORS IN THE HUMAN VESTIBULAR PERIPHERY - IMPLICATIONS FOR PHARMACOTHERAPY, The American journal of otology, 18(5), 1997, pp. 648-654
Citations number
49
Categorie Soggetti
Otorhinolaryngology
ISSN journal
01929763
Volume
18
Issue
5
Year of publication
1997
Pages
648 - 654
Database
ISI
SICI code
0192-9763(1997)18:5<648:MCOMRI>2.0.ZU;2-X
Abstract
Hypothesis: Muscarinic acetylcholine receptor subtypes are expressed i n the human vestibular periphery to receive efferent innervation on th e type II vestibular hair cells and primary afferent dendrites. Backgr ound: Previous immunohistochemical and electrophysiologic studies have shown that acetylcholine (ACh) is likely the primary neurotransmitter of the efferent vestibular periphery. The structural distribution of nicotinic receptors (nAChR) and muscarinic receptors (mAChR) are not w ell established in the human vestibular periphery. Methods: Reverse tr anscription polymerase chain reaction (RT-PCR) was used to study the e xpression of all five mAChR subtypes in Scarpa's ganglia and the vesti bular end-organs of the rat and human. Results: The authors found mi t hrough m5 expression in rats. and mi, m2, and m5 expression in humans. Conclusions: These studies show evidence that both muscarinic acetylc holine receptors sire present in the human vestibular periphery in add ition to the nicotinic receptors reported previously. The pharmacologi c implications of these data are discussed.